Licensed options in the UK include orlistat (oral), semaglutide 2.4 mg (Wegovy, approved by NICE TA875 for eligible patients), and tirzepatide (Mounjaro for type 2 diabetes
Clinical trials have shown that patients taking Tirzepatide lost an average of 15% to 20% of their body weight
Athletes subject to drug testing should consult a sports medicine physician familiar with WADA rules before considering any of these compounds
Clinical trials have been known to show that patients taking Semaglutide GLP-1 can lose an average of 5-10% of their body weight in the first month of using the treatment
Taking oral semaglutide on an empty stomach with only 120mL of water, then waiting 30 minutes before eating, optimizes absorption while reducing nausea
I have patients who travel who have told me that oral options arent just a preference, theyre a practical necessity